Dear Editor, In discussion with colleagues around the world, we have identified a critical gap of guidance for clinicians to communicate with patients and their families about how to minimize… Click to show full abstract
Dear Editor, In discussion with colleagues around the world, we have identified a critical gap of guidance for clinicians to communicate with patients and their families about how to minimize exposure whilst undertaking crucial eye care services during the current COVID-19 pandemic. In the current environment, patients with neovascular agerelated macular degeneration (nAMD) and their families are concerned and anxious about attending regular appointments to maintain their vision due to the risk of exposure. The safety and well-being of our patients are of the utmost importance. The impact of a recurring treatment schedule during this pandemic, where there are severe restrictions on clinical services and social distancing measures, is among the important aspects to be addressed. Firstly, a clear explanation of infection prevention protocols and safeguards of each clinic, including what to expect before, during, and after the appointment, may help to alleviate concerns. We assessed international retinal practices and noted a lack of consistent evidence-based guidelines or readily available information for clinicians to communicate to their patients on how their clinics are adapting in response to COVID-19. We at the Vision Academy [1], with support from Bayer, have compiled a guidance document that explains how to adapt clinic practices to minimize risk of exposure of patients and medical staff, and to prioritize those with the greatest treatment need [2]. The suggestions are based on the latest clinical recommendations [3], which can be adapted to local regulations and standards. In addition, we have developed a communication template [4] that can be used as a proactive tool, to be sent via email or text message, to patients and their families ahead of their appointment to reassure them that their safety and eye health remains a priority. A shortened version of the guidance document is provided below (full version available elsewhere [2]). Informing patients and families about what to expect at the next appointment
               
Click one of the above tabs to view related content.